EarlySense, an Israeli company which makes a passive and contactless bedside monitor that continuously measures respiration rate, heart rate, and motion, has raised $20 million, with $10 million constituting a strategic investment from Samsung. Welch Allyn, which licenses EarlySense's sensor, also contributed, as did other existing investors Pitango Venture Capital, JK&B, Proseed and Noaber...
